Bdelloid rotifers shrug off radiation doses that would obliterate human cells. Here’s how their resilience reveals deep insights into the limits of biological endurance.

They live in our houses, drink our water and even sleep in our beds. Cats have become an integral part of many households and ...

A silent revolution is unfolding inside Indian laboratories. From the patent-free power of an indigenous CRISPR tool to ...

Compared with human-specific transcriptional factors, human-specific lncRNAs identified upon human lncRNAs’ orthologs in mammals have greatly evolved DNA-binding sites in archaic and modern humans in ...

Learn about comparative gene expression studies in Alzheimer's disease and other conditions in Mayo Clinic's Precision Medicine in Neurodegeneration Lab.

A study published in the journal Science reveals how jumping fragments of human DNA, a type of genetic parasite, destabilize the cancer genome. Unstable genomes are a fertile playground for cancer ...

Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:30 AM EDTCompany ParticipantsAmy Parison - Senior VP ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...

Trained on 9 trillion DNA base pairs from every domain of life, the Evo 2 model can predict disease-causing mutations, identify genomic features and generate entirely new genetic sequences.

Scientists have uncovered the oldest known genome of the bacterium responsible for syphilis, revealing a previously unknown lineage that existed thousands of years ago in the Americas.

Researchers create a massive single-cell atlas of the aging mouse brain, revealing how epigenetic changes and "jumping genes" drive neurodegeneration.

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.